NSE IPO: SEBI nod held up by SBI-SBICAPS share allocation
Synopsis
SEBI's clearance for the NSE IPO is on hold — not because of a regulatory red flag, but because of an internal share reallocation within the SBI group. SBICAPS has joined SBI as a co-seller, splitting the original stake, and until that transfer is legally completed and reflected in the DRHP, the regulator cannot move forward. The twist: SBICAPS is also one of the bankers managing the very same IPO.
Key Takeaways
SEBI has not yet issued observations on the NSE IPO , pending completion of an internal share transfer within the SBI group .
SBI will sell up to 15.97 million NSE shares and SBICAPS will sell up to 8.78 million shares under the revised structure.
The overall offer size remains unchanged — the restructuring is an internal reallocation, not an expansion.
NSE has updated its DRHP via an addendum; the formal share transfer must be completed before SEBI can proceed.
SBICAPS holds a dual role — both selling shareholder and lead merchant banker on the NSE IPO.
The Securities and Exchange Board of India (SEBI) has yet to issue its observations on the proposed initial public offering of the National Stock Exchange (NSE), with the regulatory process stalled pending completion of an internal share allocation between State Bank of India (SBI) and its subsidiary SBI Capital Markets Ltd (SBICAPS), according to a highly placed source. The development marks a fresh procedural step in what is expected to be one of India's most closely watched capital market transactions.
What Changed in the Selling Shareholder Structure
The delay follows a revision to the NSE IPO's selling shareholder structure, under which SBICAPS has been added alongside SBI as a selling shareholder. The two entities will now jointly offload shares that were originally proposed to be sold by SBI alone.
Under the revised arrangement, SBI will sell up to 15.97 million NSE shares, while SBICAPS will sell up to 8.78 million shares. Crucially, the overall size of the offer remains unchanged — the restructuring is an internal reallocation within the SBI group and does not expand the total offering.
DRHP Update and Regulatory Timeline
NSE has already updated its draft red herring prospectus (DRHP) through an addendum to reflect the revised allocation. However, the actual transfer of shares between the two SBI group entities is expected to take additional time. According to the source, the share transfer and corresponding documentation must be formally completed and incorporated into the DRHP before SEBI can advance its review and issue its observations on the IPO application.
The proposed NSE IPO is structured entirely as an offer for sale (OFS) by existing shareholders, with no fresh issue of shares by the exchange itself. This means the internal restructuring has no bearing on the overall offer size or the exchange's capital base.
SBICAPS' Dual Role Draws Attention
Notably, SBICAPS' inclusion as a selling shareholder introduces a dual role for the firm. SBICAPS is also one of the lead merchant bankers managing the NSE IPO, meaning it will simultaneously act as a selling shareholder and as an investment bank advising on and managing the issue. This dual positioning is significant from a governance and disclosure standpoint, and is expected to be addressed in the updated DRHP.
What Happens Next
The NSE IPO has been long anticipated, and each procedural development is closely tracked by institutional investors and market participants. Once the share transfer between SBI and SBICAPS is completed and the DRHP reflects the finalised structure, SEBI will be in a position to process the application further and issue its formal observations — a key milestone before the IPO can proceed to pricing and listing.
The broader timeline for the public listing remains contingent on the pace of this internal restructuring and the regulator's subsequent review.
Point of View
Not punitive — but it underscores how even internal group restructurings can slow India's regulatory clock. More substantively, SBICAPS' dual role as selling shareholder and lead manager deserves scrutiny: the conflict-of-interest disclosure framework will be tested. SEBI has in recent years tightened norms around merchant banker conduct; how it handles this dual-role arrangement could set a precedent for future large OFS transactions where group entities wear multiple hats.
NationPress
24 Aug 2026
Frequently Asked Questions
Why is SEBI yet to issue observations on the NSE IPO?
SEBI's observations are on hold because a share allocation process between SBI and its subsidiary SBICAPS must be completed first. The revised shareholding structure needs to be formally reflected in NSE's DRHP before the regulator can advance its review.
What is the revised share allocation between SBI and SBICAPS for the NSE IPO?
Under the revised arrangement, SBI will sell up to 15.97 million NSE shares and SBICAPS will sell up to 8.78 million shares. The total offer size remains unchanged from the original proposal.
Does the SBI-SBICAPS restructuring change the size of the NSE IPO?
No. The restructuring is an internal reallocation within the SBI group and does not alter the overall size of the offering. The NSE IPO is structured as a pure offer for sale with no fresh issue of shares.
What is SBICAPS' dual role in the NSE IPO?
SBICAPS is both a selling shareholder in the NSE IPO and one of the lead merchant bankers managing the issue. This dual positioning is notable from a governance and disclosure perspective and is expected to be addressed in the updated DRHP.
What needs to happen before the NSE IPO can move forward?
The share transfer between SBI and SBICAPS must be legally completed, and the updated details must be incorporated into NSE's DRHP. Only after these steps can SEBI issue its formal observations, which is a prerequisite for the IPO to proceed to pricing and listing.
